Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype

Gianna Camiciottoli, Francesca Bigazzi, Valentina Luzzi, Elena Torricelli, Matteo Vannini, Alessio Garcea, Lorenzo Corsi, Matteo Paoletti, Lucia Cestelli, Massimo Pistolesi
European Respiratory Journal 2013 42: P3680; DOI:
Gianna Camiciottoli
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Bigazzi
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Luzzi
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Torricelli
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matteo Vannini
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessio Garcea
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenzo Corsi
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matteo Paoletti
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucia Cestelli
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Pistolesi
1Clinical and Experimental Medicine, University of Florence, Florence, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

COPD is a heterogeneous disorder with extrapulmonary manifestations. Multivariate models based on sputum features and whole lung function allow patients to be classified in a graph whose coordinates CT1and CT2 reflect COPD phenotype and severity as assessed by CT (Camiciottoli,G et al. ERJ in press). Phenotypic characteristics range progressively from airway predominant (AP)(CT1-) to emphysema predominant (EP)(CT1+). Severity of COPD increases progressively from CT2- to CT2+. In 242 COPD patients we assessed prevalence of Hypertension(H), Coronary Artery Disease(CAD), Peripheral Arterial Disease(PAD), Heart failure(HF), Diabetes(D),Osteoporosis(O), and Psychological Disorders(PD).We compared prevalence among subsets partitioned according to COPD phenotype and severity

View this table:
  • View inline
  • View popup

View this table:
  • View inline
  • View popup

Cardiovascular comorbidities are very common in COPD, with the highest prevalence in milder disease (CT2-) irrespective of the phenotype,suggesting that COPD severity progression is allowed to patients without concomitant cardiovascular comorbidity. These data support recent findings of excess mortality in GOLD B with respect to GOLD C patients and underline the need to suspect,diagnose and treat cardiovascular comorbidities in early stages of COPD.

  • COPD - diagnosis
  • Comorbidities
  • COPD - management
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Gianna Camiciottoli, Francesca Bigazzi, Valentina Luzzi, Elena Torricelli, Matteo Vannini, Alessio Garcea, Lorenzo Corsi, Matteo Paoletti, Lucia Cestelli, Massimo Pistolesi
European Respiratory Journal Sep 2013, 42 (Suppl 57) P3680;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Gianna Camiciottoli, Francesca Bigazzi, Valentina Luzzi, Elena Torricelli, Matteo Vannini, Alessio Garcea, Lorenzo Corsi, Matteo Paoletti, Lucia Cestelli, Massimo Pistolesi
European Respiratory Journal Sep 2013, 42 (Suppl 57) P3680;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
  • LATE-BREAKING ABSTRACT: Which predictors in COPD patients with the frequent exacerbator phenotype predict the treatment response to maintenance therapy with azithromycin?
  • LATE-BREAKING ABSTRACT: Intra-day symptoms fluctuations: STORICO, observational study on the characterization of 24-hour symptoms in COPD patients
Show more 1.1 Clinical Problems

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society